A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis

Completed · Phase 2 · Has a placebo group

Conditions studied: Generalized Myasthenia Gravis

In brief

The purpose of this study is to evaluate the safety, tolerability, and efficacy of M281 administered to participants with generalized myasthenia gravis (gMG) who have an insufficient clinical response to ongoing standard of care therapy.

Key facts

Study ID

NCT03772587

Run by

Momenta Pharmaceuticals, Inc.

People needed

68

Starts

2019-04-10

Expected to finish

2020-06-25

Last updated by the study team

2023-06-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Momenta Investigational Site — Tucson, Arizona, United States
• Momenta Investigational Site — Los Angeles, California, United States
• Momenta Investigational Site — Orange, California, United States
• Momenta Investigational Site — Stanford, California, United States
• Momenta Investigational Site — Aurora, Colorado, United States
• Momenta Investigational Site — New Haven, Connecticut, United States
• Momenta Investigational Site — Boca Raton, Florida, United States
• Momenta Investigational Site — Maitland, Florida, United States
• Momenta Investigational Site — Port Charlotte, Florida, United States
• Momenta Investigational Site — St. Petersburg, Florida, United States
• Momenta Investigational Site — Augusta, Georgia, United States
• Momenta Investigational Site — Meridian, Idaho, United States
• Momenta Investigational Site — Lake Barrington, Illinois, United States
• Momenta Investigational Site — Fairway, Kansas, United States
• Momenta Investigational Site — Boston, Massachusetts, United States
• Momenta Investigational Site — Boston, Massachusetts, United States
• Momenta Investigational Site — Boston, Massachusetts, United States
• Momenta Investigational Site — Detroit, Michigan, United States
• Momenta Investigational Site — East Lansing, Michigan, United States
• Momenta Investigational Site — Columbia, Missouri, United States
• Momenta Investigational Site — New Brunswick, New Jersey, United States
• Momenta Investigational Site — New York, New York, United States
• Momenta Investigational Site — Charlotte, North Carolina, United States
• Momenta Investigational Site — Durham, North Carolina, United States
• Momenta Investigational Site — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.